{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:33:27Z","timestamp":1791113607056,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":3636,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.2353\/ajpath.2010.090578","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T22:01:38Z","timestamp":1262210498000},"page":"619-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["eNOS Knockout Mice with Advanced Diabetic Nephropathy Have Less Benefit from Renin-Angiotensin Blockade than from Aldosterone Receptor Antagonists"],"prefix":"10.1016","volume":"176","author":[{"given":"Tomoki","family":"Kosugi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Heinig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2010.090578_bib1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy: The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2010.090578_bib2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2010.090578_bib3","first-page":"172","article-title":"Antihypertensive drug utilization in hypertensive veterans with complex medication profiles","volume":"2","author":"Carter","year":"2000","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.2353\/ajpath.2010.090578_bib4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1345\/aph.19346","article-title":"The use of ACE inhibitors as renoprotective agents in Medicaid patients with diabetes","volume":"34","author":"Scarsi","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.2353\/ajpath.2010.090578_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.HYP.0000028979.98877.0C","article-title":"ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO","volume":"40","author":"Shiuchi","year":"2002","journal-title":"Hypertension"},{"key":"10.2353\/ajpath.2010.090578_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.ki.5001652","article-title":"Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency","volume":"70","author":"Chan","year":"2006","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2010.090578_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/jc.2005-1632","article-title":"Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy","volume":"91","author":"Jawa","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.2353\/ajpath.2010.090578_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.amjcard.2004.04.022","article-title":"Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-Brachial Artery Reactivity Study)","volume":"94","author":"Papaioannou","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.2353\/ajpath.2010.090578_bib9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/ndt\/gfm828","article-title":"Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin","volume":"23","author":"Yilmaz","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.2353\/ajpath.2010.090578_bib10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2007.060481","article-title":"Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice","volume":"170","author":"Kanetsuna","year":"2007","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.090578_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.2006050459","article-title":"Diabetic eNOS knockout mice develop advanced diabetic nephropathy","volume":"18","author":"Nakagawa","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2010.090578_bib12","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1681\/ASN.2006070798","article-title":"Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice","volume":"17","author":"Zhao","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2010.090578_bib13","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2353\/ajpath.2009.080605","article-title":"Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice","volume":"174","author":"Kosugi","year":"2009","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2010.090578_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.2004080648","article-title":"Mouse models of diabetic nephropathy","volume":"16","author":"Breyer","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2010.090578_bib15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/labinvest.3700599","article-title":"Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy","volume":"87","author":"Kosugi","year":"2007","journal-title":"Lab Invest"},{"key":"10.2353\/ajpath.2010.090578_bib16","doi-asserted-by":"crossref","first-page":"F658","DOI":"10.1152\/ajprenal.00040.2004","article-title":"Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells","volume":"287","author":"Nakagawa","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.2353\/ajpath.2010.090578_bib17","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1152\/ajpregu.00645.2006","article-title":"Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension","volume":"293","author":"Franco","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.2353\/ajpath.2010.090578_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.HYP.23.6.982","article-title":"Sympathetic baroreceptor responses after chronic NG-nitro-L-arginine methyl ester treatment in conscious rats","volume":"23","author":"Scrogin","year":"1994","journal-title":"Hypertension"},{"key":"10.2353\/ajpath.2010.090578_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/10641968009046427","article-title":"Baroreflex sensitivity in rabbits during the development of experimental renal hypertension and medial sclerosis","volume":"2","author":"Angell-James","year":"1980","journal-title":"Clin Exp Hypertens"},{"key":"10.2353\/ajpath.2010.090578_bib20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"10.2353\/ajpath.2010.090578_bib21","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa021835","article-title":"Regression of microalbuminuria in type 1 diabetes","volume":"348","author":"Perkins","year":"2003","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2010.090578_bib22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.ki.5000159","article-title":"ACE-inhibitor use and the long-term risk of renal failure in diabetes","volume":"69","author":"Suissa","year":"2006","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2010.090578_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1046\/j.1523-1755.1999.055003984.x","article-title":"Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade","volume":"55","author":"Ruggenenti","year":"1999","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2010.090578_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2010.090578_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.2353\/ajpath.2010.090578_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701.x","article-title":"Aldosterone in the development and progression of renal injury","volume":"66","author":"Hollenberg","year":"2004","journal-title":"Kidney Int"},{"key":"10.2353\/ajpath.2010.090578_bib27","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1007\/s00125-004-1542-0","article-title":"Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate","volume":"47","author":"Schjoedt","year":"2004","journal-title":"Diabetologia"},{"key":"10.2353\/ajpath.2010.090578_bib28","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1172\/JCI21398","article-title":"Inhibition of diabetic nephropathy by a decoy peptide corresponding to the \u201chandle\u201d region for nonproteolytic activation of prorenin","volume":"114","author":"Ichihara","year":"2004","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2010.090578_bib29","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1681\/ASN.2006010029","article-title":"Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice","volume":"17","author":"Ichihara","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.2353\/ajpath.2010.090578_bib30","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s00125-007-0795-9","article-title":"Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats","volume":"50","author":"Kelly","year":"2007","journal-title":"Diabetologia"},{"key":"10.2353\/ajpath.2010.090578_bib31","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving","year":"2008","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401060377X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401060377X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:04:06Z","timestamp":1757599446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294401060377X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S000294401060377X"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2010.090578","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"eNOS Knockout Mice with Advanced Diabetic Nephropathy Have Less Benefit from Renin-Angiotensin Blockade than from Aldosterone Receptor Antagonists","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2010.090578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}